Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 25;19(9):12940-8.
doi: 10.3390/molecules190912940.

Effect of chlorogenic acid on melanogenesis of B16 melanoma cells

Affiliations

Effect of chlorogenic acid on melanogenesis of B16 melanoma cells

Hao-Rong Li et al. Molecules. .

Abstract

Chlorogenic acid (CGA), the ester formed between caffeic acid and l-quinic acid, is a widespread phenolic compound. It is part of the human diet, found in foods such as coffee, apples, pears, etc. CGA is also was widely used in cosmetics, but the effects of CGA on melanogenesis are unknown. In this study, we analyzed the effects of CGA on cell proliferation, melanin content and tyrosinase of B16 murine melanoma cells. Additionally, the enzymatic reactions of CGA in B16 melanoma cells lytic solution were detected by UV spectrophotometry. Results showed CGA at 30 and 60 μM significantly suppresses cell proliferation. 8-MOP at 100 μM significantly promotes cell proliferation, but CGA can counter this. Incubated for 24 h, CGA (500 μM) improves melanogenesis while suppressing tyrosinase activity in B16 melanoma cells or 8-methoxypsoralen (8-MOP) co-incubated B16 melanoma cells. After 12 h, B16 melanoma cell treatment with CGA leads to an increase in melanin accumulation, however, after 48 h there is a decrease in melanin production which correlates broadly with a decrease in tyrosinase activity. CGA incubated with lytic solution 24 h turned brown at 37 °C. The formation of new products (with a maximum absorption at 295 nm) is associated with reduction of CGA (maximum absorption at 326 nm). Therefore, CGA has its two sidesroles in melanogenesis of B16 melanoma cells. CGA is a likely a substrate of melanin, but the metabolic product(s) of CGA may suppress melanogenesis in B16 melanoma cells by inhibiting tyrosinase activity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The chemical structures of chlorogenic acid, tyrosine and l-Dopa. (A) Chlorogenic acid; (B) Tyrosine; (C) l-Dopa.
Figure 2
Figure 2
The effects of CGA on the cell proliferation of B16 melanoma cells and 8-MOP-treated B16 melanoma cells. Each value represents the mean ± SE (n = 3). * p < 0.05, compared with the control.
Figure 3
Figure 3
The effects of CGA on the melanin content (Mel) and tyrosinase activity (Tyr) of B16 melanoma cells and 8-MOP treated B16 melanoma cells, treated 24 h (A), 48 h (B). Each value represents the mean ± SE (n = 3). * p < 0.05, compared with the control. ** p < 0.01, compared with the control. # p < 0.05, compared with the 100 μM 8-MOP. ## p < 0.01, compared with the 100 μM 8-MOP.
Figure 4
Figure 4
(A) Absorption spectra of CGA (0.5 mM) incubated with lytic solution (20 U/mL) at different incubation times; (B) Monitoring absorbance at 326 nm and 400 nm in time during incubations of CGA (0.5 mM) with lytic solution (20 U/mL); (C) CGA (0.5 mM) with lytic solution (20 U/mL) incubate 24 h in 37 °C.

Similar articles

Cited by

References

    1. Upadhyay R., Mohan Rao L.J. An outlook on chlorogenic acids—Occurrence, chemistry, technology, and biological activities. Crit. Rev. Food Sci. Nutr. 2013;53:968–984. doi: 10.1080/10408398.2011.576319. - DOI - PubMed
    1. Scharffetter-Kochanek K., Wlaschek M., Brenneisen P., Schauen M., Blaudschun R., Wenk J. UV-induced reactive oxygen species in photocarcinogenesis and photoaging. Biol. Chem. 1997;378:1247–1257. - PubMed
    1. Gaudout D., Megard D., Inisan C., Esteve C., Lejard F. Phloridzin-Rich Phenolic Fraction and Use Thereof as a Cosmetic, Dietary or Nutraceutical Agent. 7427418 B2. U.S. Patent. 2008 Sep 23;
    1. Gaudout D., Megard D., Lejard F. Use of a Dihydrochalcone-Rich Phenolic Fraction in a Cosmetic Treatment. 7285298. U.S. Patent. 2007 Oct 23;
    1. Kim Y.-J., Uyama H. Tyrosinase inhibitors from natural and synthetic sources: Structure, inhibition mechanism and perspective for the future. Cell. Mol. Life Sci. CMLS. 2005;62:1707–1723. doi: 10.1007/s00018-005-5054-y. - DOI - PMC - PubMed

Publication types